These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3104706)

  • 1. [Treatment of nasopharyngeal cancer with recombinant gamma interferon (IFN). A report based on 2 patients].
    Zanetti F; Elies S
    Laryngol Rhinol Otol (Stuttg); 1987 Jan; 66(1):54-6. PubMed ID: 3104706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
    Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
    Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
    Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
    Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
    J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH).
    Mertens R; Granzen B; Lassay L; Bucsky P; Hundgen M; Stetter G; Heimann G; Weiss C; Hess CF; Gademann G
    Cancer; 2005 Sep; 104(5):1083-9. PubMed ID: 15999363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal carcinoma: evidence for improved survival with combined chemoradiation.
    Smith TL; DiRugguero DC; Weissler MC
    Ear Nose Throat J; 1998 Jun; 77(6):484-9. PubMed ID: 9674323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
    Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
    Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of advanced nasopharyngeal carcinoma treated with radiotherapy combined with DDP and vindesine].
    Liu M; Liu H; Mao Z
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):54-6. PubMed ID: 11776799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy for carcinoma of the nasopharynx: a report of 49 cases.
    Sheng H; Jia H
    J Laryngol Otol; 1993 Mar; 107(3):201-4. PubMed ID: 8509695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
    Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
    J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duokangjiasu combined with radiotherapy in the treatment of 32 nasopharyngeal carcinoma (NPC) patients].
    Li QQ
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):299-300. PubMed ID: 3248490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.